CN103074337B - Herpes simplex virus DNA sequence and its application - Google Patents

Herpes simplex virus DNA sequence and its application Download PDF

Info

Publication number
CN103074337B
CN103074337B CN201210513622.5A CN201210513622A CN103074337B CN 103074337 B CN103074337 B CN 103074337B CN 201210513622 A CN201210513622 A CN 201210513622A CN 103074337 B CN103074337 B CN 103074337B
Authority
CN
China
Prior art keywords
sequence
herpes simplex
simplex virus
hsv
virus dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210513622.5A
Other languages
Chinese (zh)
Other versions
CN103074337A (en
Inventor
马明星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Huanji Biological Technology Co ltd
Original Assignee
KUNMING HUANJI BIOLOGICAL CHIP INDUSTRY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KUNMING HUANJI BIOLOGICAL CHIP INDUSTRY Co Ltd filed Critical KUNMING HUANJI BIOLOGICAL CHIP INDUSTRY Co Ltd
Priority to CN201210513622.5A priority Critical patent/CN103074337B/en
Publication of CN103074337A publication Critical patent/CN103074337A/en
Application granted granted Critical
Publication of CN103074337B publication Critical patent/CN103074337B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to a herpes simplex virus DNA sequence and its application, and belongs to the technical field of the biomedicine. The specificity and the PCR amplimer of herpes simplex virus DNA are determined through searching and analyzing gene database data, and the length of the sequence is 217bp. The sequence is obtained through the PCR amplification and the cloning of a human herpes simplex virus infection sample, and sequencing tests prove that the sequence is consistent with a predicted sequence. The specificity of the sequence to the herpes simplex virus DNA is verified by the results of bioinformatics method analysis and gene chip hybridization analysis. The herpes simplex virus DNA sequence can be used for herpes simplex virus diagnosis as a gene chip diagnosis probe and a PCR amplification detection sequence. A method used by the clinical detection technology established in the invention has the advantages of rapidness, accuracy, simple operation, low cost and the like.

Description

One section of herpes simplex virus dna sequence and application
Technical field:
Invention relates to DNA sequence dna and the application of one section of hsv HSV, belongs to field of biomedicine technology.
Background technology:
(Herpes simplexvirus, HSv) is spherical in shape for hsv, and intact virus forms core containing distrand DNA by core, capsid, tunicle (Tegument) and cyst membrane, is wound in fibril spool.Capsid is icosahedron symmetry, by 162 shell ultrafine particles compositions, diameter 100nm.The outer one deck tunicle of capsid covers, gage distortion, and outermost layer is typical double-layer of lipoid cyst membrane, above has projection.The viral diameter that has cyst membrane is 150~200nm.Cyst membrane surface is containing gb, gC, gD, gE, gG, gH glycoprotein, with virus to cell adsorb/penetrate (gB gC gD ge), control virus from nuclear membrane sprout releases (gH) and inducing cell fusion (gbgC gD gH) relevant.And have and induce neutralizing antibody (gd is the strongest) and cytotoxicity (known HSV glycoprotein all can).
HSV genome is a linear DNA molecule, is made up of covalently bound long segment (L) and short-movie section (S).Every fragment all contains unique sequence and Inverted repeat.In genome, have 72 genes, the 70 different protein of encoding altogether, wherein, except the characteristic of 24 kinds of albumen is not clear, form viral DNA in conjunction with albumen and various enzyme by 18 kinds of proteins encoded, participate in viral DNA synthetic, the metabolism of packaging and Nucleotide etc.The different albumen composition virus structural proteins of kind more than 30 (as capsid protein, envelope protein), at the DNA of protection HSV, and play an important role in the pathogenic effects of HSV and induction immune response.
HSV can grow in various kinds of cell, and conventional clone has bhk cell, Vero cell, Hep-2 cell etc.Virus is first while separating, and primary newborn rabbit kidney cell, human embryonic lung cell are more responsive.HSV infection animal is in extensive range, many animals intracranial inoculation can cause herpes simplex encephalitis, small white mouse is that footpad inoculation can cause central nervous system lethal infection, and rabbit cornea inoculation causes herpetic keratitis, and the inoculation of cavy intravaginal can cause cervicitis and cervical cancer.On inoculated into chick embryo chorioallantoic membrane, form proliferative white patch.
Virus is main by direct close contact and transmission through sex.The number of ways such as HSV direct oral cavity, respiratory tract, reproductive tract mucous membrane and damaged skin are invaded body.People infects very general, and infection rate reaches 80~90%, and common clinical manifestation is the bleb that mucous membrane or local skin gather, and serious systemic disease also can occur occasionally, involves internal organ.
Within 6 months, obtain antibody so that interior baby is many from parent by placenta, primary infection approximately 90%, without clinical symptom, mostly is inapparent infection.Primary infection often betides 1~15 years old, common are gingivostomatitis, ties up to buccal mucosa and bleb in groups occurs at gums place, after breaking, and many lid layers necrotic tissue.In addition can cause herpes labialis, eczema sample bleb, herpetic keratitis, herpes simplex encephalitis etc.After genital herpes is more common in 14 years old, more serious, local severe pain, with heating general malaise and poradenolymphitis.
HSV primary infection produces after immunizing power, and part virus can arrive in gasserian ganglion and spinal nerve section cell or around in star-shaped glial cell, with latent state sustainable existence, in relative equilibrium, not cause clinical symptom with body along neural myelin.When organism fever, catch cold, Exposure to Sunlight, menstruation, nervous, use hypophysis or adrenocortical hormone, suffer some bacteriovirus infection etc., the activated viral propagation of hiding, come downwards to sensory nerve ending along nerve fiber rope, to near epidermic cell, continue propagation, cause the local bleb of recurrent.Be characterized in recurring pathology at every turn and often betide same position.The most common between lip nose skin and mucous membrane intersection there is exanthema vesiculosum in groups.Herpetic keratitis, herpetic cervicitis etc. also can be shown effect repeatedly.
HSV, by placental infection, affects embryonic cell mitotic division, easily miscarries, causes the congenital disorders such as fetal anomaly, mental retardation.Approximately 40~60% newborn infant can be infected in the time of the birth canal by infecting, and occurs high heat, expiratory dyspnea and central nervous system pathological change, wherein 60~70% be contaminted newborn infant can be therefore and dead, in survivor, sequela can reach 95%.
Summary of the invention:
The invention reside in by information biology and Protocols in Molecular Biology, determined DNA sequence dna and the PCR primer thereof of one section of hsv HSV, this sequence and accordingly PCR primer can be used for setting up gene chip and PCR method is carried out the diagnosis of one section of hsv.
Technical scheme of the present invention is:
One section of hsv (HSV) DNA sequence dna that the present invention has determined that length is 217bp and primer thereof, carry out pcr amplification with described primer, and its sequence is as follows:
GTCTGTTTGG GCTTGTCGTT ATGGGAGCCT GGGGGGCGTG GGGTGGGTCA CAGGCAACCG 60
AATATGTTCT TCGTAGTGTT ATTGCCAAAG AGGTGGGGGA CATACTAAGA GTGCCTTGCA 120
TGCGGACCCC CGCGGACGAT GTTTCTTGGC GCTACGAGGC CCCGTCCGTT ATTGACTATG 180
CCCGCGTAGA CGGAATATTT CTTCGCTATC ACTGCCC 217
Amplification PCR primer is:
A.5’-GTCTGTTTGG GCTTGTCGTT-3’
B.5’-GGGCAGTGAT AGCGAAGAAA-3’。
Above-mentioned one section of hsv (HSV) DNA sequence dna is used for the probe sequence of the gene chip of diagnosing HSV, and carries out pcr amplification by above-mentioned primer sequence, carries out hybridization check or be directly used in PCR diagnosis after mark.
The method that the clinical detection technique that the present invention sets up uses has the advantages such as quick, accurate, easy and simple to handle, with low cost.
Brief description of the drawings:
Fig. 1 is the pcr amplification collection of illustrative plates of clinical samples.
Fig. 2 is the order-checking collection of illustrative plates of this sequence.
Fig. 3 is to the sequencing result of pcr amplification product and the comparative analysis of estimating sequence with Blast software.
Fig. 4 is Blast Search Results in gene database.
Fig. 5 and Fig. 5 are continuous is gene chip hybridization result.
Embodiment:
First taking hsv as keyword, in gene database, search for the nucleotide sequence of simplexvirus.Obtain altogether several nucleotide sequences in close relations, these nucleotide sequences are used to the nucleotide sequence (nr) in software comparison gene database online with the online Blast of NCBI, get rid of nonspecific nucleotide sequence, obtain the specific nucleotide sequence of 217bp, with this section of sequences Design 1 pair of PCR primer, extract DNA with clinical samples, carry out pcr amplification, screen a pair of sequence and the primer that is applicable to carrying out pcr amplification, the product that pcr amplification obtains is in the same size in estimating, see Fig. 1, in figure, sequence number is: 1. standard molecular weight DNA, molecular size range is respectively under upper: 600, 500, 400, 300, 200, 100, 2. clinical positive sample, amplified production is very pure, and big or small 200 left and right are in the same size with expectation, 3. clinical ' negative ' specimens, does not have amplified production.Collection of illustrative plates result shows amplification clinical sample that can be special with the primer in the present invention.Then clone with T-vector, and order-checking, sequencer address is shown in Fig. 2, from way, 46 start, and to 262,217bp is cloned sequence altogether, all the other sequences are cloning vector sequence, sequence is 217bp, estimates sequence by the comparison of Blast software, shows consistent with the sequence of estimating, see Fig. 3, all sequences is all consistent with expectation sequence, shows that this sequence can be by specific amplification, and the PCR that can be used for HSV detects.Sequence comprises cDNA with the DNA(of the Blast muca gene database of NCBI website) sequence, this sequence is only consistent with the sequence of HSV, and there is no homology with other species sequence, see Fig. 4, search result shows to only have the plasmid dna sequence of HSV in this sequence homology, and be to match completely, and other sequence only has short sequence to match with it, and because not having primer, these sequences match therewith, therefore can not be detected in detection.With after this sequence mark as probe the gene chip hybridization with 80 sites of the other 18 kinds of viral pathogenic infection things that contain urogenital infections disease and 15 hypotype HPV, only have sequence of the present invention to have therewith hybridization signal, and other all sequences amixia signal therewith, see that Fig. 5, Fig. 5 are continuous, in figure, be four repetitions, results of hybridization shows to only have this sequence to have special signal, and other equal amixia signal shows that this sequence is the distinguished sequence of HSV virus.
The present invention can be used for PCR method or method for gene chip and carries out the clinical detection of urogenital infections disease and 15 hypotype HPV.Carry out pcr amplification by sequence provided by the invention, obtain according to PCR method whether product occurs and the big or small infection that determines whether HSV virus.Also can be used for this sequence is probe, as a detection site in gene chip, then with the PCR primer sequence amplification clinical samples in the present invention, and after mark, carries out hybridization check.
HSV sequence table
Specification sheets sequence table
Organization Applicant
----------------------
Street: 6th floors, Economic Development Zone, Kunming, Yunnan Province Information Technology Industry Base returned student undertaking area Building 3
City: Kunming
State: Yunnan Province
Country: China
PostalCode:650000
PhoneNumber:0871-8314895
FaxNumber:0871-8318952
EmailAddress:kmydsh1999@163.com
<110>OrganizationName: Kunming Huanji Biochip Development Co., Ltd
Application Project
-------------------
<120>Title:
<130>AppFileReference:
<140>CurrentAppNumber:
<141>CurrentFilingDate:____-__-__
Sequence
--------
<213>OrganismName:Herpes simplex virus
<400>PreSequenceString:
GTCTGTTTGG GCTTGTCGTT ATGGGAGCCT GGGGGGCGTG GGGTGGGTCA CAGGCAACCG 60
AATATGTTCT TCGTAGTGTT ATTGCCAAAG AGGTGGGGGA CATACTAAGA GTGCCTTGCA 120
TGCGGACCCC CGCGGACGAT GTTTCTTGGC GCTACGAGGC CCCGTCCGTT ATTGACTATG 180
CCCGCGTAGA CGGAATATTT CTTCGCTATC ACTGCCC 217
<212>Type:DNA
<211>Length:217
SequenceName: one section of hsv (HSV) DNA detection sequence.

Claims (2)

1. one section of herpes simplex virus dna sequence, is characterized in that, the length of this sequence is 217bp, and sequence is as follows:
GTCTGTTTGG GCTTGTCGTT ATGGGAGCCT GGGGGGCGTG GGGTGGGTCA CAGGCAACCG 60
AATATGTTCT TCGTAGTGTT ATTGCCAAAG AGGTGGGGGA CATACTAAGA GTGCCTTGCA 120
TGCGGACCCC CGCGGACGAT GTTTCTTGGC GCTACGAGGC CCCGTCCGTT ATTGACTATG 180
CCCGCGTAGA CGGAATATTT CTTCGCTATC ACTGCCC 217
Amplification PCR primer is:
A.5’-GTCTGTTTGG GCTTGTCGTT-3’
B.5’-GGGCAGTGAT AGCGAAGAAA-3’。
2. the application of one section of herpes simplex virus dna sequence as claimed in claim 1 in the reagent for the preparation of detection hsv, it is characterized in that the probe sequence of this sequence as the gene chip for detection of hsv, and carry out pcr amplification by primer A and B, after mark, carry out hybridization check, described pcr amplification primer is:
A.5’-GTCTGTTTGG GCTTGTCGTT-3’
B.5’-GGGCAGTGAT AGCGAAGAAA-3’。
CN201210513622.5A 2012-12-04 2012-12-04 Herpes simplex virus DNA sequence and its application Active CN103074337B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210513622.5A CN103074337B (en) 2012-12-04 2012-12-04 Herpes simplex virus DNA sequence and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210513622.5A CN103074337B (en) 2012-12-04 2012-12-04 Herpes simplex virus DNA sequence and its application

Publications (2)

Publication Number Publication Date
CN103074337A CN103074337A (en) 2013-05-01
CN103074337B true CN103074337B (en) 2014-07-09

Family

ID=48151032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210513622.5A Active CN103074337B (en) 2012-12-04 2012-12-04 Herpes simplex virus DNA sequence and its application

Country Status (1)

Country Link
CN (1) CN103074337B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011132078A2 (en) * 2010-04-23 2011-10-27 Genomic Vision Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing
CN102458463A (en) * 2009-05-22 2012-05-16 健诺西生物科学公司 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458463A (en) * 2009-05-22 2012-05-16 健诺西生物科学公司 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2011132078A2 (en) * 2010-04-23 2011-10-27 Genomic Vision Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Conejero Godberg et al.Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue.《Bio Techniques》.2005,第39卷(第5期),第741-751页.
Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue;Conejero Godberg et al;《Bio Techniques》;20051130;第39卷(第5期);第741-751页 *

Also Published As

Publication number Publication date
CN103074337A (en) 2013-05-01

Similar Documents

Publication Publication Date Title
CN108220484B (en) Kit for simultaneously detecting EBV, CMV and HSV-6 herpes viruses by one-step method and detection method
CN111693712B (en) Method for detecting SARS-CoV-2N protein of new coronavirus by using nucleic acid aptamer
Antinone et al. Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis
Beisser et al. Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain
CN101463396B (en) African hog cholera virus fluorescent quantitative PCR detecting reagent and preparation and use thereof
Yang et al. Retrograde, transneuronal spread of pseudorabies virus in defined neuronal circuitry of the rat brain is facilitated by gE mutations that reduce virulence
US5824466A (en) Purified polypeptide of human papillomavirus type 49 (HPV49) type 50 (HVP50), and type 55 (HPV55)
Butchi et al. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists
WO2022227942A1 (en) Hepatitis b virus surface protein mutant and application thereof in anti-hepatitis b virus
WO2023066396A1 (en) Core amino acid sequence group for targeted recognition of anti-sars-cov-2 neutralizing antibodies n-igy-pabs, and use thereof
Ceroni et al. Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray
WO2014079350A1 (en) Cho cell dna detection method
CN106442981B (en) A kind of 1 type antibody indirect ELISA diagnostic kit of human bocavirus
Chowdhury et al. Bovine herpesvirus 5 (BHV-5) Us9 is essential for BHV-5 neuropathogenesis
CN105002298B (en) A kind of fluorescent quantitative PCR detection method of huichun viremia virus
WO2023040026A1 (en) Immunochromatographic detection reagent strip and kit comprising same, and applications of both
CN105886663A (en) Locked nucleic acid sensitivity-enhanced fluorescent quantitative PCR (polymerase chain reaction) detection reagent kit for wild strains of porcine pseudorabies viruses
Wellehan et al. Six novel gammaherpesviruses of Afrotheria provide insight into the early divergence of the Gammaherpesvirinae
CN111596070B (en) Application of portunus trituberculatus tropomyosin allergy detection reagent
Sinha et al. COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy
KR20210123234A (en) Recombinant nucleocapsid protein for diagnosis and vaccine of COVID-19 and use thereof
CN103074337B (en) Herpes simplex virus DNA sequence and its application
Wang et al. Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants
CN106636149A (en) Serine/threonine protein kinase Pj_STPK gene cloning and prokaryotic expression method and application of parabronema skrjabini
CN106636462A (en) Nested PCR primers and method for detecting drug-resistant mutation of cytomegalovirus UL54 and UL97 genes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20130501

Assignee: Fujian atlas biological science and Technology Co.,Ltd.

Assignor: KUNMING HUANJI BIOLOGICAL CHIP INDUSTRY Co.,Ltd.

Contract record no.: 2018530000011

Denomination of invention: Herpes simplex virus DNA sequence and its application

Granted publication date: 20140709

License type: Exclusive License

Record date: 20180620

EE01 Entry into force of recordation of patent licensing contract
TR01 Transfer of patent right

Effective date of registration: 20230418

Address after: 130000 4th floor, building 4, Hongda optoelectronics Industrial Park, No. 789, Shunda Road, high tech Zone, Changchun City, Jilin Province

Patentee after: JILIN HUANJI BIOLOGICAL TECHNOLOGY CO.,LTD.

Address before: 650000, 6th Floor, Building 3, Overseas Returnees Entrepreneurship Park, Information Industry Base, Economic and Technological Development Zone, Kunming City, Yunnan Province

Patentee before: KUNMING HUANJI BIOLOGICAL CHIP INDUSTRY Co.,Ltd.

TR01 Transfer of patent right